0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $100 | May 2023
    Product Insights

    DHA Cap – 70 Mallory Avenue Mixed-Use Complex – New Jersey

    Equip yourself with the essential tools needed to make informed and profitable decisions with our DHA Cap - 70 Mallory Avenue Mixed-Use Complex - New Jersey report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...

  • Product Insights

    $100 | May 2023
    Product Insights

    DHA – D-Homme Residential Tower – Ho Chi Minh City

    Equip yourself with the essential tools needed to make informed and profitable decisions with our DHA - D-Homme Residential Tower - Ho Chi Minh City report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...

  • Company Profile

    $295 | February 2024
    Company Profile

    Dominari Holdings Inc – Company Profile

    Dominari Holdings Inc (Dominari Holdings), formerly AIkido Pharma Inc, a biotechnology company that develops early stage small-molecule anti-cancer therapeutics. Its therapy areas include acute myeloid leukemia, pancreatic cancer and acute lymphoblastic leukemia. The company pipeline products include KPC34 developed in preclinical studies for the treatment of acute lymphoblastic leukemia and acute myeloid leukemia and DHA-dFdC developed in preclinical studies for treatment of pancreatic cancer. Dominari Holdings is headquartered in New York, the US.

    Add to Basket
  • Company Profile

    $295 | November 2023
    Company Profile

    Corbion NV – Company Profile

    Corbion NV (Corbion) manufactures and supplies biochemical, biomedical, bioplastic, and food ingredient solutions. The company’s product offerings include lactic acid and its derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients. It offers food solutions to various businesses such as bakeries, meat, confectionery, poultry, oils, dairy, seafood, shortening and margarine, beverages, fruits, and vegetables, refrigerated food and emulsifiers. Corbion caters to biochemical solutions for agrochemicals, pharma, animal health and nutrition, chemicals, home care, and personal care. The company markets...

    Add to Basket
  • Company Profile

    New
    $295 | February 2024
    Company Profile
    New

    TherapeuticsMD Inc

    TherapeuticsMD Inc (TherapeuticsMD) is an innovative pharmaceutical company. It develops products to address the unique changes and challenges women experience throughout the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The company's major products portfolio includes segesterone acetate and ethinyl estradiol, estradiol and progesterone capsules, prenatal vitamins, estradiol vaginal inserts. The company sells its products under the various brands name of VitamedMD, BocagreenMD, Annovera, Bijuva, vitaPearl, vitaTrue, vitaMedMD One Rx, FOLMAX,...

    Add to Basket
  • Product Insights

    $500 | November 2022
    Product Insights

    Net Present Value Model: Lotriga

    Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Lotriga Drug Details Omega-3-acid ethyl esters...

  • Product Insights

    $500 | November 2022
    Product Insights

    Likelihood of Approval and Phase Transition Success Rate Model – fenretinide

    Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry fenretinide Drug Details Fenretinide (LAU-7b) is under development for the treatment of cystic fibrosis...

  • Product Insights

    $500 | November 2022
    Product Insights

    Likelihood of Approval and Phase Transition Success Rate Model – SC-411

    Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SC-411 Drug Details SC-411 is under development for the treatment of acute sickle cell...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.